Loibl S, Marme F, Martin M, Untch M, et al. Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial. J Clin Oncol 2021 Apr 1:JCO2003639. doi: 10.1200/JCO.20.03639.
PMID: 33793299